| Objective: To clarify the clinical efficacy and safety of treating gastric ulcer by clinical observation of gastric ulcer(hepatogastric stagnation syndrome).Method: A total of 67 patients met the inclusion criteria.Patients were randomly divided into 2 groups.The treatment group consisted of 34 patients.On the basis of treatment with Huagan Jianwei,combined application of rabeprazole sodium enteric-coated tablets(20mg once daily In the morning),a total of 33 patients in the control group were treated with oral administration of rabeprazole sodium enteric-coated tablets.4 weeks for a course of treatment,both groups of patients were treated for 1 course of treatment,during the course of treatment were closely observed and recorded changes in symptoms and signs of the two groups of patients before and after treatment to observe the status of endoscopic staging,and statistical analysis,before and after the treatment of the two groups Patients were observed for safety indicators once.Result: A total of 67 patients completed the trial,34 patients in the treatment group and33 in the control group.The total effective rate was 91.18% in the treatment group and72.73% in the control group.After statistical analysis,P=0.009< 0.01,there was a significant difference in the total effective rate between the two groups,indicating that the clinical effect of the treatment group was significantly better than that of the control group.Comparing gastroscopy between the two groups,the total effective rate in the treatment group was88.24%;the total effective rate in the control group was 75.76%.Statistical analysis P=0.021<0.05,which was statistically significant,indicating that the ulcer healing condition under the gastroscope was better in the treatment group than in the control group.After statistical analysis of the symptoms of each group of traditional Chinese medicine patients,the two groups showed significant differences in improving stomach pain,heartburn or burning sensation,hi cold drink,dry mouth,bitter taste and irritability(P<0.05).In conditioning constipation,there was a significant difference between the treatment group and the control group(P<0.01).There was no significant difference between the two groups in improving the patient’s belching and pantothenic acid(P>0.05).No safety indicators were found in both groups after treatment.Conclusion: The treatment of gastric ulcer caused by liver and stomach stagnation syndrome can effectively improve the clinical symptoms of patients with gastric ulcer,increase the healing rate of gastric ulcer,and have a significant clinical effect on the treatment of gastric ulcer. |